Kamada (Kamada) 3-Year Revenue Growth Rate : -3.90% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Kamada 3-Year Revenue Growth Rate?

Kamada's Revenue per Share for the three months ended in Dec. 2023 was $0.64.

During the past 12 months, Kamada's average Revenue per Share Growth Rate was -7.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -3.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Kamada was 61.80% per year. The lowest was -8.70% per year. And the median was 4.00% per year.

Competitive Comparison of Kamada's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kamada's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Kamada's 3-Year Revenue Growth Rate falls into.

Kamada 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Kamada (NAS:KMDA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Kamada 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Kamada's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (Kamada) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

KMDA:Israel

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.